Pravin Shejul, Ph.D., Ll.B.
About Pravin Shejul, Ph.D., Ll.B.
Pravin Shejul, Ph.D., Ll.B., serves as the Director of Intellectual Property at OmniActive Health Technologies, where he has worked since 2019. He has extensive experience in the pharmaceutical industry, having held various roles in intellectual property management and litigation across multiple organizations.
Current Role at OmniActive Health Technologies
Pravin Shejul, Ph.D., Ll.B. serves as the Director of Intellectual Property at OmniActive Health Technologies since 2019. In this role, he is responsible for overseeing the company's IP strategy and management. His responsibilities include providing advisory services for obtaining, renewing, defending, and enforcing patents. Shejul's work demonstrates a comprehensive approach to intellectual property management, crucial for the company's operations in the health technology sector.
Previous Experience in Pharmaceutical Industry
Shejul has extensive experience in the pharmaceutical industry, having held several key positions. He worked at Glenmark Pharmaceuticals as a Senior Scientist in the Discovery Division from 2003 to 2006. He later joined Genesen Labs Ltd (Janssen Cilag India) as a Senior Manager of Intellectual Property from 2006 to 2012. He also served as Deputy General Manager (Head) of IP at Wanbury Limited from 2015 to 2019 and as Assistant General Manager (Head) of IP at the same company from 2012 to 2015.
Educational Background and Qualifications
Pravin Shejul holds a Doctor of Philosophy (Ph.D.) in Medicinal Chemistry from the University of Aberdeen, completed from 2003 to 2006. He also earned a Bachelor’s Degree in General Law & Intellectual Property from the University of Mumbai between 2010 and 2013. Additionally, he has a Master’s Degree in Chemistry from Amravati University, obtained from 1999 to 2001, and a Bachelor’s Degree in Chemistry from the same institution, completed from 1996 to 1999.
Skills in Intellectual Property Management
Shejul is skilled in drafting various intellectual property agreements, including Confidential Disclosure Agreements (CDA), Joint Development Agreements (JDA), and licenses. His expertise aligns with legal and global IP management standards. He has extensive experience handling litigation related to P-IV filings and method of use cases, which are critical in the pharmaceutical industry. Additionally, he has planned and executed day-to-day IP activities, including conducting non-infringement and freedom-to-operate studies.
Research and Development Contributions
Throughout his career, Pravin Shejul has contributed to the planning and execution of strategies for differentiated and niche generic product portfolios. His work showcases his expertise in creating unique market offerings within the pharmaceutical sector. He has also been involved in research projects during his tenure as a Junior Research Fellow at Nagpur University, where he worked on the CIL-KITS Project from 2001 to 2002.